Qube Research & Technologies LTD Outset Medical, Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OM
# of Institutions
91Shares Held
19.9MCall Options Held
66.8KPut Options Held
60.3K-
Vanguard Group Inc Valley Forge, PA2.64MShares$2.09 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$1.49 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.81MShares$1.43 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA1.47MShares$1.16 Million0.04% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.39MShares$1.1 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $37.9M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...